Callan JMB Inc. (CJMB)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | - | - | 23 | 13 | 7 | 6 | 5 | - |
| Operating profit | $m | -6 | -7 | ||||||
| Net profit | $m | - | - | 6 | 2 | -2 | -8 | -10 | - |
| EPS reported | $ | -1.82 | -2.00 | ||||||
| Operating cashflow per share | $ | -1.04 | -0.80 | ||||||
| Capex per share | $ | 0.14 | 0.07 | ||||||
| FCF per share | $ | -1.18 | -0.73 | ||||||
| Free cash flow | $m | -5 | -4 | ||||||
| Net debt | $m | -2 | -1 | ||||||
| Book value equity | $m | 2 | 1 | ||||||
| Book value per share | $ | 0.53 | 0.12 | ||||||
| Number of shares | m | 4.38 | 5.65 | ||||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | - | ||||||
| P/B LTM | x | 2.09 | 7.13 | ||||||
| P/S LTM | x | 0.85 | 0.96 | ||||||
| P/FCF LTM | x | -0.94 | -1.18 | ||||||
| EV/EBITDA LTM | x | -0.61 | -0.49 | ||||||
| EV/Sales LTM | x | 0.83 | 2.23 | ||||||
| Earnings Yield LTM | % | -1.64% | -82.02% | ||||||
| FCF Yield | % | -106.22% | -84.74% | ||||||
| Quality | |||||||||
| ROE | % | -342.19% | -444.91% | ||||||
| ROIC | % | -1.38% | -2.02% | ||||||
| Operating margin | % | -1.13% | -1.35% | ||||||
| Gross margin | % | +36.77% | +39.94% | ||||||
| FCF/Sales | % | -90.22% | -80.94% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | -12.80% | -22.45% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | - | - | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | -100.00% | -100.00% | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | -2.58 | -1.92 | ||||||
| Net Debt/EBITDA | x | 0.02 | -0.13 | ||||||
| EBIT/Net interest | x | -2,427.10 | -1,370.04 | ||||||
| Net debt/market cap | % | +0.30% | 0.00% | ||||||
| Net debt/Equity | x | -0.91 | -1.26 | ||||||
| Gross debt/equity | x | 0.86 | 3.14 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Callan JMB Inc., operating primarily through its subsidiary Coldchain Technology Services, LLC, specializes in providing temperature-controlled logistics solutions specifically for the life sciences sector. The company's services include comprehensive frozen shipping capabilities essential for a wide range of sensitive biological and medical materials. These critical shipments encompass items such as personalized medicines, cell-based therapies, stem cells, cell lines, vaccines, diagnostic samples, reproductive materials (including semen, eggs, and embryos), cord blood, organs, biopharmaceutical products, infectious substances, and other vital commodities. Additionally, Callan JMB Inc. offers packaging services for other perishable (non-pharmaceutical) client goods, alongside technical support. The company was founded in 2006 and is based in Spring Branch, Texas.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Not enough data to calculate KvantraRank
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Callan JMB Inc., operating primarily through its subsidiary Coldchain Technology Services, LLC, specializes in providing temperature-controlled logistics solutions specifically for the life sciences sector. The company's services include comprehensive frozen shipping capabilities essential for a wide range of sensitive biological and medical materials. These critical shipments encompass items such as personalized medicines, cell-based therapies, stem cells, cell lines, vaccines, diagnostic samples, reproductive materials (including semen, eggs, and embryos), cord blood, organs, biopharmaceutical products, infectious substances, and other vital commodities. Additionally, Callan JMB Inc. offers packaging services for other perishable (non-pharmaceutical) client goods, alongside technical support. The company was founded in 2006 and is based in Spring Branch, Texas.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free